Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3Tyr705 Pathway.
Saved in:
| Title: | Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3Tyr705 Pathway. |
|---|---|
| Authors: | Sim J; Department of Biomedical Science, College of Life Science CHA University Seongnam Republic of Korea.; CHA Future Medicine Research Institute CHA Bundang Medical Center Seongnam Republic of Korea., Park J; Department of Medicine, College of Medicine Hallym University Chuncheon Republic of Korea., Heo J; Department of Pathology, Bundang CHA Medical Center CHA University College of Medicine Seongnam Republic of Korea., Kim YJ; Department of Biomedical Science, College of Life Science CHA University Seongnam Republic of Korea.; CHA Future Medicine Research Institute CHA Bundang Medical Center Seongnam Republic of Korea., Kim D; Department of Biomedical Science, College of Life Science CHA University Seongnam Republic of Korea.; CHA Future Medicine Research Institute CHA Bundang Medical Center Seongnam Republic of Korea., Jeon YH; Preclinical Research Center (PRC) Daegu-Gyeonbuk Medical Innovation Foundation (K-Medi Hub) Daegu Republic of Korea., Lee JE; Preclinical Research Center (PRC) Daegu-Gyeonbuk Medical Innovation Foundation (K-Medi Hub) Daegu Republic of Korea., Choi SH; Department of Radiology Pusan National University Hospital Biomedical Institute of Pusan National University Hospital Pusan National University School of Medicine Busan Republic of Korea., Kim HJ; Department of Radiology Pusan National University Hospital Biomedical Institute of Pusan National University Hospital Pusan National University School of Medicine Busan Republic of Korea., Hwang SJ; Department of Neurosurgery Bundang CHA Medical Center CHA University College of Medicine Seongnam Republic of Korea.; Development Division CG Cell Corporation Seongnam Republic of Korea., Kim J; Department of Integrated Biomedical Science Soonchunhyang Institute of Medi-bio Science (SIMS) Soonchunhyang University Cheonan Republic of Korea.; Department of Biology Education Kongju National University Gongju Republic of Korea., Cho KG; Department of Neurosurgery Bundang CHA Medical Center CHA University College of Medicine Seongnam Republic of Korea., Yoo J; Department of Neurosurgery Brain Tumor Center Gangnam Severance Hospital Seoul Republic of Korea., Moon JH; Department of Neurosurgery Endoscopic Skull Base Center Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea., Moon JS; Department of Integrated Biomedical Science Soonchunhyang Institute of Medi-bio Science (SIMS) Soonchunhyang University Cheonan Republic of Korea.; Department of Pathology College of Medicine Soonchunhyang University Cheonan Republic of Korea., Sung KS; Department of Neurosurgery Dong-A University Hospital, Dong-A University College of Medicine Busan Republic of Korea., Lim J; Department of Biomedical Science, College of Life Science CHA University Seongnam Republic of Korea.; CHA Future Medicine Research Institute CHA Bundang Medical Center Seongnam Republic of Korea.; Department of Neurosurgery Bundang CHA Medical Center CHA University College of Medicine Seongnam Republic of Korea. |
| Source: | MedComm [MedComm (2020)] 2026 Jan 18; Vol. 7 (2), pp. e70593. Date of Electronic Publication: 2026 Jan 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.70593 |
